Summary
This prediction is currently active. The price of Altimmune has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.91%. This prediction currently runs until 18.03.27. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Altimmune | -4.323% | -4.323% |
| iShares Core DAX® | 0.437% | 5.640% |
| iShares Nasdaq 100 | 1.057% | 0.282% |
| iShares Nikkei 225® | 1.769% | 0.406% |
| iShares S&P 500 | 0.368% | 1.920% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Altimmune diskutieren
Altimmune (ALT) is now covered by Truist Financial Corporation. They set a "buy" rating and a $12.00 price target on the stock.
Ratings data for ALT provided by MarketBeat